Pharmaceutical companies are confronted with particular challenges that include stringent regulations, higher awareness about barriers’ performance on the side of buyers, and increasing interest in scalable systems. Among the most important pharmaceutical packaging design trends today are advanced barrier materials, patient-centric dispensing systems, and packaging formats that support both regulatory compliance and product stability.
The global pharmaceutical packaging market had a value of USD 149.97 billion in 2024 and is expected to be worth USD 371.36 billion in 2033, witnessing a CAGR of 10.6% during 2026-2033. Within that, plastics and polymers lead material demand, driven by their barrier properties and compatibility with complex topical formulations.
For procurement managers evaluating pharmaceutical package manufacturers, the question is no longer just “can the supplier make a tube?” It’s: does the supplier understand what goes inside it.
1. Barrier Performance Has Become the Baseline
A few years ago, brands buying tubes for medicated creams or natural cosmetics were happy with single-layer PE. However, formulations with active ingredients, such as antifungals, retinoids, botanical actives, antiseptic compounds like povidone-iodine or chlorhexidine, degrade when exposed to oxygen.
A monolayer tube offers no protection against that.
EVOH (ethylene vinyl alcohol) co-extruded barrier tubes have moved from a premium option to a practical requirement for sensitive formulations. According to Future Market Insights, EVOH leads the barrier tube packaging market with a 28% share, precisely because of its oxygen-barrier performance for pharmaceutical and personal care products.
What the Layers Do in a Co-Ex Tube
Co-extruded tubes have the following layers:
- Outer PE layer: printable surface, brand decoration
- Tie layers: bonding agents between incompatible materials
- EVOH core: blocks oxygen transmission to protect formulation
- Inner PE layer: direct contact with product, must be pharma-grade
For procurement teams, the specification question to ask any pharmaceutical package manufacturer is whether they can produce multi-layer CO-EX structures with a documented EVOH barrier.
2. Tube Format Is a Formula Decision, Not Just a Branding Choice
Different formulations dispense differently. Healthcare packaging design trends in 2025–2026 reflect a shift toward matching tube geometry to application method rather than defaulting to standard round tubes.
| Tube Format | Best For | Key Feature |
| Round CO-EX Tube | Standard ointments, creams | Uniform squeeze, versatile printing area |
| Oval CO-EX Tube | Ergonomic hand-held products | Flat profile, premium shelf presence |
| Nozzle Tube | Precise topical application, OTC gels | Controlled orifice (1-8mm), reduced waste |
| Pump Tube | Serums, high-viscosity formulations | No-touch dispensing, dose consistency |
| Lip Gloss Tube | OTC lip care, topical lip treatments | Small-volume, precision fill |
| Super Oval Tube | Premium OTC and cosmetic-pharma crossovers | Distinct shelf silhouette, larger label area |
3. Regulatory Compliance Is Now a Supplier Qualification Criterion
Regulatory readiness has become one of the defining pharmaceutical packaging design trends, as brands increasingly prioritize suppliers that can provide comprehensive documentation and support for global market requirements.
Buyers sourcing tubes for the US, UK, EU, or Australian market face documentation requirements that many tube suppliers are not equipped to handle. The minimum to expect from a pharmaceutical package manufacturer exporting to regulated markets:
- ISO 9001:2015 certification with batch-level traceability
- Material Safety Data Sheets (MSDS) for all resins
- Certificate of Analysis (CoA) per production batch
- Heavy metal test reports on PE and barrier materials
- Compatibility testing support for formulation-tube interaction
- FDA Drug Master File (DMF) support capability for US registrations
GMP compliance, or active GMP pursuit, is increasingly expected even for primary packaging suppliers, not just manufacturers of the drug itself. Buyers who skip this step during supplier qualification often discover the gap at audit, not before.
4. Patient-Centric Design Is Changing What “Usable” Means
Healthcare packaging design trends in 2026 put usability alongside safety. Pharmapack 2025 flagged patient-centric design as one of the defining concerns in pharmaceutical packaging, covering dispensing precision, clarity of labelling, and ease of use for elderly or low-dexterity users.
For tube packaging, this translates into specific technical decisions:
- Cap type: The choice of cap type, screw-on FTC vs. snap-fit vs. standby cap, affects one-handed usability
- Orifice diameter: Precision nozzle tips reduce over-dispensing for high-cost formulations
- Print clarity: High-contrast text and barcode printing support regulatory text readability
- Tube length and diameter: Must match fill volume without leaving dead space or causing shoulder collapse
None of these are aesthetic decisions. Each one is a functional specification that should appear in the supplier’s technical brief before sampling begins.
5. Decoration Quality in Pharma Packaging Is a Compliance Issue
Drug facts panels, schedule H markings, dosage instructions, barcodes, and lot numbers must survive the tube’s entire shelf life without fading, rubbing off, or misregistering. This makes decoration a regulatory concern.
The standards to hold a supplier to:
- Color-to-Pantone matching with documented LAB and Delta values
- Print registration tolerance of ±0.3mm or tighter
- Hot stamping position accuracy of ±0.5mm
- Print adhesion testing for long-term surface compatibility
A supplier running 8-color offset printing with in-house pre-press and batch-level print verification can meet these requirements. One relying on outsourced decoration rarely can
What to Verify Before Issuing a Purchase Order
As pharmaceutical packaging design trends continue to evolve, procurement teams are placing greater emphasis on barrier performance, supplier certifications, decoration capabilities, and manufacturing scalability during vendor evaluation.
Here is what experienced pharma packaging buyers consistently ask before committing to a tube supplier:
| Criterion | Why It Matters |
| CO-EX vs. monolayer capability | EVOH barrier is non-negotiable for oxygen-sensitive formulations |
| MOQ per SKU | Low MOQs (e.g. 10,000 units) allow multi-SKU flexibility without overstock |
| Lead time post-artwork approval | 15-day lead time is the usable benchmark for most export programs |
| ISO certification scope | ISO 9001 + 14001 + 45001 signals a managed, auditable operation |
| Documentation package | MSDS, CoA, heavy metal reports are table stakes for regulated markets |
| In-house decoration | Reduces coordination risk and keeps color accuracy under one roof |
Wrapping Up: Pharmaceutical Packaging Design Trends Shaping the Industry
EVOH barriers, precision nozzle formats, documented compliance chains, and print that survives shelf life are the specs that separate packaging that qualifies from packaging that looks good on a sample sheet.According to Grand View Research, the global pharmaceutical packaging market is projected to grow at a CAGR of 9.9% from 2026 to 2033. For procurement teams, that growth means more supplier options and a greater need for a clear qualification framework.
Frequently Asked Questions
Why is tamper-evident packaging important for pharmaceutical products?
Tamper-evident packaging helps protect product integrity and consumer safety by providing visible signs of interference. It also supports regulatory compliance and strengthens patient confidence in the authenticity of healthcare products.
How is sustainability influencing pharmaceutical packaging design?
Sustainability is driving demand for recyclable materials, reduced plastic usage, lightweight packaging, and manufacturing processes with lower environmental impact. Many pharmaceutical brands are balancing environmental goals with product protection and regulatory requirements.
How does packaging affect pharmaceutical product shelf life?
Packaging materials and barrier properties directly influence a product’s resistance to moisture, oxygen, light, and contamination. Proper packaging selection helps maintain formulation stability and ensures the product remains effective throughout its intended shelf life.
Can pharmaceutical packaging be customized without affecting compliance?
Yes, packaging can be customized through shape, decoration, dispensing systems, and branding elements while maintaining regulatory compliance. However, all modifications must preserve product protection, label readability, traceability, and required safety information.
